Forgentiq.ai

Forgentiq is an AI-driven biotechnology company specializing in the generative design of biologics, with a core focus on de novo antibody discovery. The company leverages proprietary deep learning models and protein language architectures to design novel therapeutic candidates with high affinity and specificity. By integrating computational predictions with rapid experimental validation, Forgentiq aims to overcome the limitations of traditional library-based discovery methods. Their platform is designed to accelerate the development of next-generation treatments across various therapeutic areas, including oncology and immunology. The company represents a new wave of AI-first drug discovery firms focused on the complex space of large molecule therapeutics.